Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 40 entries
Sorted by: Best Match Show Resources per page
Unusual Enhancement of Doxorubicin Activity on Co-Delivery with Polyhedral Oligomeric Silsesquioxane (POSS).

Materials (Basel, Switzerland)

Sobierajska E, Konopka M, Janaszewska A, Piorecka K, Blauz A, Klajnert-Maculewicz B, Stanczyk M, Stanczyk WA.
PMID: 28772919
Materials (Basel). 2017 May 20;10(5). doi: 10.3390/ma10050559.

Polyhedral oligomeric silsesquioxane (POSS), bearing eight 3-chloroammoniumpropyl substituents, was studied as a potential nanocarrier in co-delivery systems with doxorubicin (DOX). The toxicity of doxorubicin and POSS:DOX complexes at four different molar ratios (1:1; 1:2, 1:4, 1:8) towards microvascular endothelial...

Cite
Sobierajska E, Konopka M, Janaszewska A, et al. Unusual Enhancement of Doxorubicin Activity on Co-Delivery with Polyhedral Oligomeric Silsesquioxane (POSS). Materials (Basel). 2017;10(5)doi: 10.3390/ma10050559.
Sobierajska, E., Konopka, M., Janaszewska, A., Piorecka, K., Blauz, A., Klajnert-Maculewicz, B., Stanczyk, M., & Stanczyk, W. A. (2017). Unusual Enhancement of Doxorubicin Activity on Co-Delivery with Polyhedral Oligomeric Silsesquioxane (POSS). Materials (Basel, Switzerland), 10(5), . https://doi.org/10.3390/ma10050559
Sobierajska, Ewelina, et al. "Unusual Enhancement of Doxorubicin Activity on Co-Delivery with Polyhedral Oligomeric Silsesquioxane (POSS)." Materials (Basel, Switzerland) vol. 10,5 (2017). doi: https://doi.org/10.3390/ma10050559
Sobierajska E, Konopka M, Janaszewska A, Piorecka K, Blauz A, Klajnert-Maculewicz B, Stanczyk M, Stanczyk WA. Unusual Enhancement of Doxorubicin Activity on Co-Delivery with Polyhedral Oligomeric Silsesquioxane (POSS). Materials (Basel). 2017 May 20;10(5). doi: 10.3390/ma10050559. PMID: 28772919; PMCID: PMC5459003.
Copy Download .nbib Format: NLM
Reprint of "Use of medroxyprogesterone acetate for hormone therapy in postmenopausal women: Is it safe?".

The Journal of steroid biochemistry and molecular biology

Stanczyk FZ, Bhavnani BR.
PMID: 26291834
J Steroid Biochem Mol Biol. 2015 Sep;153:151-9. doi: 10.1016/j.jsbmb.2015.08.013. Epub 2015 Aug 19.

Medroxyprogesterone acetate (MPA) has been in clinical use for over 30 years, and was generally considered to be safe until the results of long-term studies of postmenopausal hormone therapy (HT) using treatment with conjugated equine estrogens (CEE) combined with...

Cite
Stanczyk FZ, Bhavnani BR. Reprint of "Use of medroxyprogesterone acetate for hormone therapy in postmenopausal women: Is it safe?". J Steroid Biochem Mol Biol. 2015;153:151-9doi: 10.1016/j.jsbmb.2015.08.013.
Stanczyk, F. Z., & Bhavnani, B. R. (2015). Reprint of "Use of medroxyprogesterone acetate for hormone therapy in postmenopausal women: Is it safe?". The Journal of steroid biochemistry and molecular biology, 153151-9. https://doi.org/10.1016/j.jsbmb.2015.08.013
Stanczyk, Frank Z, and Bhavnani, Bhagu R. "Reprint of "Use of medroxyprogesterone acetate for hormone therapy in postmenopausal women: Is it safe?"." The Journal of steroid biochemistry and molecular biology vol. 153 (2015): 151-9. doi: https://doi.org/10.1016/j.jsbmb.2015.08.013
Stanczyk FZ, Bhavnani BR. Reprint of "Use of medroxyprogesterone acetate for hormone therapy in postmenopausal women: Is it safe?". J Steroid Biochem Mol Biol. 2015 Sep;153:151-9. doi: 10.1016/j.jsbmb.2015.08.013. Epub 2015 Aug 19. PMID: 26291834.
Copy Download .nbib Format: NLM
Genetic variants and non-genetic factors predict circulating vitamin D levels in Hispanic and non-Hispanic White women: the Breast Cancer Health Disparities Study.

International journal of molecular epidemiology and genetics

Wang W, Ingles SA, Torres-Mejía G, Stern MC, Stanczyk FZ, Schwartz GG, Nelson DO, Fejerman L, Wolff RK, Slattery ML, John EM.
PMID: 24596595
Int J Mol Epidemiol Genet. 2014 Feb 17;5(1):31-46. eCollection 2014.

Genome-wide association studies (GWAS) have identified common polymorphisms in or near GC, CYP2R1, CYP24A1, and NADSYN1/DHCR7 genes to be associated with circulating levels of 25-hydroxyvitamin D [25(OH)D] in European populations. To replicate these GWAS findings, we examined six selected...

Cite
Wang W, Ingles SA, Torres-Mejía G, et al. Genetic variants and non-genetic factors predict circulating vitamin D levels in Hispanic and non-Hispanic White women: the Breast Cancer Health Disparities Study. Int J Mol Epidemiol Genet. 2014;5(1):31-46
Wang, W., Ingles, S. A., Torres-Mejía, G., Stern, M. C., Stanczyk, F. Z., Schwartz, G. G., Nelson, D. O., Fejerman, L., Wolff, R. K., Slattery, M. L., & John, E. M. (2014). Genetic variants and non-genetic factors predict circulating vitamin D levels in Hispanic and non-Hispanic White women: the Breast Cancer Health Disparities Study. International journal of molecular epidemiology and genetics, 5(1), 31-46.
Wang, Wei, et al. "Genetic variants and non-genetic factors predict circulating vitamin D levels in Hispanic and non-Hispanic White women: the Breast Cancer Health Disparities Study." International journal of molecular epidemiology and genetics vol. 5,1 (2014): 31-46.
Wang W, Ingles SA, Torres-Mejía G, Stern MC, Stanczyk FZ, Schwartz GG, Nelson DO, Fejerman L, Wolff RK, Slattery ML, John EM. Genetic variants and non-genetic factors predict circulating vitamin D levels in Hispanic and non-Hispanic White women: the Breast Cancer Health Disparities Study. Int J Mol Epidemiol Genet. 2014 Feb 17;5(1):31-46. eCollection 2014. PMID: 24596595; PMCID: PMC3939005.
Copy Download .nbib Format: NLM
Surface Photochemical Corrosion as a Mechanism for Fast Degradation of InGaN UV Laser Diodes.

ACS applied materials & interfaces

Marona L, Wisniewski P, Wzorek M, Smalc-Koziorowska J, Grzanka S, Bojarska-Cieslinska A, Schiavon D, Stanczyk S, Czerwinski A, Czyszanowski T, Perlin P.
PMID: 33161712
ACS Appl Mater Interfaces. 2020 Nov 18;12(46):52089-52094. doi: 10.1021/acsami.0c11864. Epub 2020 Nov 08.

We studied degradation mechanisms of ultraviolet InGaN laser diodes emitting in the UVA range. Short wavelength nitride devices are subjected to much faster degradation, under the same packaging and testing conditions, than their longer wavelength counterparts. Transmission electron microscopy...

Cite
Marona L, Wisniewski P, Wzorek M, et al. Surface Photochemical Corrosion as a Mechanism for Fast Degradation of InGaN UV Laser Diodes. ACS Appl Mater Interfaces. 2020;12(46):52089-52094doi: 10.1021/acsami.0c11864.
Marona, L., Wisniewski, P., Wzorek, M., Smalc-Koziorowska, J., Grzanka, S., Bojarska-Cieslinska, A., Schiavon, D., Stanczyk, S., Czerwinski, A., Czyszanowski, T., & Perlin, P. (2020). Surface Photochemical Corrosion as a Mechanism for Fast Degradation of InGaN UV Laser Diodes. ACS applied materials & interfaces, 12(46), 52089-52094. https://doi.org/10.1021/acsami.0c11864
Marona, Lucja, et al. "Surface Photochemical Corrosion as a Mechanism for Fast Degradation of InGaN UV Laser Diodes." ACS applied materials & interfaces vol. 12,46 (2020): 52089-52094. doi: https://doi.org/10.1021/acsami.0c11864
Marona L, Wisniewski P, Wzorek M, Smalc-Koziorowska J, Grzanka S, Bojarska-Cieslinska A, Schiavon D, Stanczyk S, Czerwinski A, Czyszanowski T, Perlin P. Surface Photochemical Corrosion as a Mechanism for Fast Degradation of InGaN UV Laser Diodes. ACS Appl Mater Interfaces. 2020 Nov 18;12(46):52089-52094. doi: 10.1021/acsami.0c11864. Epub 2020 Nov 08. PMID: 33161712.
Copy Download .nbib Format: NLM
Molecular Mechanisms of Antitumor Activity of PAMAM Dendrimer Conjugates with Anticancer Drugs and a Monoclonal Antibody.

Polymers

Marcinkowska M, Stanczyk M, Janaszewska A, Gajek A, Ksiezak M, Dzialak P, Klajnert-Maculewicz B.
PMID: 31470686
Polymers (Basel). 2019 Aug 29;11(9). doi: 10.3390/polym11091422.

Taxanes are considered fundamental drugs in the treatment of breast cancer, but despite the similarities, docetaxel (doc) and paclitaxel (ptx) work differently. For this reason, it is interesting to identify mechanisms of antitumor activity of PAMAM dendrimer conjugates that...

Cite
Marcinkowska M, Stanczyk M, Janaszewska A, et al. Molecular Mechanisms of Antitumor Activity of PAMAM Dendrimer Conjugates with Anticancer Drugs and a Monoclonal Antibody. Polymers (Basel). 2019;11(9)doi: 10.3390/polym11091422.
Marcinkowska, M., Stanczyk, M., Janaszewska, A., Gajek, A., Ksiezak, M., Dzialak, P., & Klajnert-Maculewicz, B. (2019). Molecular Mechanisms of Antitumor Activity of PAMAM Dendrimer Conjugates with Anticancer Drugs and a Monoclonal Antibody. Polymers, 11(9), . https://doi.org/10.3390/polym11091422
Marcinkowska, Monika, et al. "Molecular Mechanisms of Antitumor Activity of PAMAM Dendrimer Conjugates with Anticancer Drugs and a Monoclonal Antibody." Polymers vol. 11,9 (2019). doi: https://doi.org/10.3390/polym11091422
Marcinkowska M, Stanczyk M, Janaszewska A, Gajek A, Ksiezak M, Dzialak P, Klajnert-Maculewicz B. Molecular Mechanisms of Antitumor Activity of PAMAM Dendrimer Conjugates with Anticancer Drugs and a Monoclonal Antibody. Polymers (Basel). 2019 Aug 29;11(9). doi: 10.3390/polym11091422. PMID: 31470686; PMCID: PMC6780640.
Copy Download .nbib Format: NLM
Effect of efavirenz on levonorgestrel concentrations among Malawian levonorgestrel implant users for up to 30 months of concomitant use: a subanalysis of a randomized clinical trial.

Contraception: X

Tang JH, Davis NL, Corbett AH, Chinula L, Cottrell ML, Zia Y, Tegha G, Stanczyk FZ, Hurst S, Hosseinipour MC, Haddad LB, Kourtis AP.
PMID: 33364598
Contracept X. 2020 May 29;2:100027. doi: 10.1016/j.conx.2020.100027. eCollection 2020.

OBJECTIVES: Our primary objective was to compare geometric mean levonorgestrel concentrations between levonorgestrel implant users who were or were not taking the antiretroviral efavirenz, for up to 30 months after implant initiation. Our secondary objective was to evaluate the...

Cite
Tang JH, Davis NL, Corbett AH, et al. Effect of efavirenz on levonorgestrel concentrations among Malawian levonorgestrel implant users for up to 30 months of concomitant use: a subanalysis of a randomized clinical trial. Contracept X. 2020;2:100027doi: 10.1016/j.conx.2020.100027.
Tang, J. H., Davis, N. L., Corbett, A. H., Chinula, L., Cottrell, M. L., Zia, Y., Tegha, G., Stanczyk, F. Z., Hurst, S., Hosseinipour, M. C., Haddad, L. B., & Kourtis, A. P. (2020). Effect of efavirenz on levonorgestrel concentrations among Malawian levonorgestrel implant users for up to 30 months of concomitant use: a subanalysis of a randomized clinical trial. Contraception: X, 2100027. https://doi.org/10.1016/j.conx.2020.100027
Tang, Jennifer H, et al. "Effect of efavirenz on levonorgestrel concentrations among Malawian levonorgestrel implant users for up to 30 months of concomitant use: a subanalysis of a randomized clinical trial." Contraception: X vol. 2 (2020): 100027. doi: https://doi.org/10.1016/j.conx.2020.100027
Tang JH, Davis NL, Corbett AH, Chinula L, Cottrell ML, Zia Y, Tegha G, Stanczyk FZ, Hurst S, Hosseinipour MC, Haddad LB, Kourtis AP. Effect of efavirenz on levonorgestrel concentrations among Malawian levonorgestrel implant users for up to 30 months of concomitant use: a subanalysis of a randomized clinical trial. Contracept X. 2020 May 29;2:100027. doi: 10.1016/j.conx.2020.100027. eCollection 2020. PMID: 33364598; PMCID: PMC7752709.
Copy Download .nbib Format: NLM
Longitudinal antimüllerian hormone and its correlation with pubertal milestones.

F&S reports

Smith MB, Ho J, Ma L, Lee M, Czerwinski SA, Glenn TL, Cool DR, Gagneux P, Stanczyk FZ, McGinnis LK, Lindheim SR.
PMID: 34278360
F S Rep. 2021 Feb 08;2(2):238-244. doi: 10.1016/j.xfre.2021.02.001. eCollection 2021 Jun.

OBJECTIVE: To examine the changes in AMH levels longitudinally over time and their relationship with both body composition, particularly abdominal adiposity, and milestones of pubertal development in female children.DESIGN: Secondary analysis of a prospective, longitudinal study.SETTING: University affiliated research...

Cite
Smith MB, Ho J, Ma L, et al. Longitudinal antimüllerian hormone and its correlation with pubertal milestones. F S Rep. 2021;2(2):238-244doi: 10.1016/j.xfre.2021.02.001.
Smith, M. B., Ho, J., Ma, L., Lee, M., Czerwinski, S. A., Glenn, T. L., Cool, D. R., Gagneux, P., Stanczyk, F. Z., McGinnis, L. K., & Lindheim, S. R. (2021). Longitudinal antimüllerian hormone and its correlation with pubertal milestones. F&S reports, 2(2), 238-244. https://doi.org/10.1016/j.xfre.2021.02.001
Smith, Meghan B, et al. "Longitudinal antimüllerian hormone and its correlation with pubertal milestones." F&S reports vol. 2,2 (2021): 238-244. doi: https://doi.org/10.1016/j.xfre.2021.02.001
Smith MB, Ho J, Ma L, Lee M, Czerwinski SA, Glenn TL, Cool DR, Gagneux P, Stanczyk FZ, McGinnis LK, Lindheim SR. Longitudinal antimüllerian hormone and its correlation with pubertal milestones. F S Rep. 2021 Feb 08;2(2):238-244. doi: 10.1016/j.xfre.2021.02.001. eCollection 2021 Jun. PMID: 34278360; PMCID: PMC8267383.
Copy Download .nbib Format: NLM
Association of bioavailable inhibin B and oocyte yield in controlled ovarian stimulation.

F&S reports

Danis RB, Sriprasert I, Ho JR, McGinnis LK, Kumar A, Stanczyk FZ.
PMID: 34278353
F S Rep. 2021 Mar 31;2(2):189-194. doi: 10.1016/j.xfre.2021.03.005. eCollection 2021 Jun.

OBJECTIVE: To determine if the biologically active or bioavailable inhibin B (bio-inhB) correlated with the oocyte yield in controlled ovarian stimulation (COS).DESIGN: Cross-sectional study.SETTING: Academic center.PATIENTS: Women undergoing oocyte cryopreservation.INTERVENTIONS: None.MAIN OUTCOME MEASURES: Serum of women were sampled to...

Cite
Danis RB, Sriprasert I, Ho JR, et al. Association of bioavailable inhibin B and oocyte yield in controlled ovarian stimulation. F S Rep. 2021;2(2):189-194doi: 10.1016/j.xfre.2021.03.005.
Danis, R. B., Sriprasert, I., Ho, J. R., McGinnis, L. K., Kumar, A., & Stanczyk, F. Z. (2021). Association of bioavailable inhibin B and oocyte yield in controlled ovarian stimulation. F&S reports, 2(2), 189-194. https://doi.org/10.1016/j.xfre.2021.03.005
Danis, Rachel B, et al. "Association of bioavailable inhibin B and oocyte yield in controlled ovarian stimulation." F&S reports vol. 2,2 (2021): 189-194. doi: https://doi.org/10.1016/j.xfre.2021.03.005
Danis RB, Sriprasert I, Ho JR, McGinnis LK, Kumar A, Stanczyk FZ. Association of bioavailable inhibin B and oocyte yield in controlled ovarian stimulation. F S Rep. 2021 Mar 31;2(2):189-194. doi: 10.1016/j.xfre.2021.03.005. eCollection 2021 Jun. PMID: 34278353; PMCID: PMC8267401.
Copy Download .nbib Format: NLM
The temporal reliability of serum estrogens, progesterone, gonadotropins, SHBG and urinary estrogen and progesterone metabolites in premenopausal women.

BMC women's health

Williams AE, Maskarinec G, Franke AA, Stanczyk FZ.
PMID: 12498620
BMC Womens Health. 2002 Dec 23;2(1):13. doi: 10.1186/1472-6874-2-13.

BACKGROUND: There is little existing research to guide researchers in estimating the minimum number of measurement occasions required to obtain reliable estimates of serum estrogens, progesterone, gonadotropins, sex hormone-binding globulin (SHBG), and urinary estrogen and progesterone metabolites in premenopausal...

Cite
Williams AE, Maskarinec G, Franke AA, et al. The temporal reliability of serum estrogens, progesterone, gonadotropins, SHBG and urinary estrogen and progesterone metabolites in premenopausal women. BMC Womens Health. 2002;2(1):13doi: 10.1186/1472-6874-2-13.
Williams, A. E., Maskarinec, G., Franke, A. A., & Stanczyk, F. Z. (2002). The temporal reliability of serum estrogens, progesterone, gonadotropins, SHBG and urinary estrogen and progesterone metabolites in premenopausal women. BMC women's health, 2(1), 13. https://doi.org/10.1186/1472-6874-2-13
Williams, Andrew E, et al. "The temporal reliability of serum estrogens, progesterone, gonadotropins, SHBG and urinary estrogen and progesterone metabolites in premenopausal women." BMC women's health vol. 2,1 (2002): 13. doi: https://doi.org/10.1186/1472-6874-2-13
Williams AE, Maskarinec G, Franke AA, Stanczyk FZ. The temporal reliability of serum estrogens, progesterone, gonadotropins, SHBG and urinary estrogen and progesterone metabolites in premenopausal women. BMC Womens Health. 2002 Dec 23;2(1):13. doi: 10.1186/1472-6874-2-13. PMID: 12498620; PMCID: PMC140038.
Copy Download .nbib Format: NLM
Recurrent arterial and venous thrombosis in a 16-year-old boy in the course of primary antiphospholipid syndrome despite treatment with low-molecular-weight heparin: a case report.

Journal of medical case reports

Biernacka-Zielinska M, Lipinska J, Szymanska-Kaluza J, Stanczyk J, Smolewska E.
PMID: 23971759
J Med Case Rep. 2013 Aug 23;7:221. doi: 10.1186/1752-1947-7-221.

INTRODUCTION: Antiphospholipid syndrome is a multisystem autoimmune disease characterized by arterial and/or venous thrombosis and persistent presence of antiphospholipid antibodies. It can be a primary disease or secondary when associated with other autoimmune diseases.CASE PRESENTATION: We present a case...

Cite
Biernacka-Zielinska M, Lipinska J, Szymanska-Kaluza J, et al. Recurrent arterial and venous thrombosis in a 16-year-old boy in the course of primary antiphospholipid syndrome despite treatment with low-molecular-weight heparin: a case report. J Med Case Rep. 2013;7:221doi: 10.1186/1752-1947-7-221.
Biernacka-Zielinska, M., Lipinska, J., Szymanska-Kaluza, J., Stanczyk, J., & Smolewska, E. (2013). Recurrent arterial and venous thrombosis in a 16-year-old boy in the course of primary antiphospholipid syndrome despite treatment with low-molecular-weight heparin: a case report. Journal of medical case reports, 7221. https://doi.org/10.1186/1752-1947-7-221
Biernacka-Zielinska, Malgorzata, et al. "Recurrent arterial and venous thrombosis in a 16-year-old boy in the course of primary antiphospholipid syndrome despite treatment with low-molecular-weight heparin: a case report." Journal of medical case reports vol. 7 (2013): 221. doi: https://doi.org/10.1186/1752-1947-7-221
Biernacka-Zielinska M, Lipinska J, Szymanska-Kaluza J, Stanczyk J, Smolewska E. Recurrent arterial and venous thrombosis in a 16-year-old boy in the course of primary antiphospholipid syndrome despite treatment with low-molecular-weight heparin: a case report. J Med Case Rep. 2013 Aug 23;7:221. doi: 10.1186/1752-1947-7-221. PMID: 23971759; PMCID: PMC3766042.
Copy Download .nbib Format: NLM
In Reply.

Menopause (New York, N.Y.)

Stanczyk FZ.
PMID: 26908207
Menopause. 2016 Apr;23(4):472-3. doi: 10.1097/GME.0000000000000639.

No abstract available.

Cite
Stanczyk FZ. In Reply. Menopause. 2016;23(4):472-3doi: 10.1097/GME.0000000000000639.
Stanczyk, F. Z. (2016). In Reply. Menopause (New York, N.Y.), 23(4), 472-3. https://doi.org/10.1097/GME.0000000000000639
Stanczyk, Frank Z. "In Reply." Menopause (New York, N.Y.) vol. 23,4 (2016): 472-3. doi: https://doi.org/10.1097/GME.0000000000000639
Stanczyk FZ. In Reply. Menopause. 2016 Apr;23(4):472-3. doi: 10.1097/GME.0000000000000639. PMID: 26908207.
Copy Download .nbib Format: NLM
Long Sun-Exposures Influencing High Sub-Cutaneous Synthesis of Vitamin-D3 may be Associated with Exacerbation of Symptoms in Allergic-Asthma.

The journal of aging research & clinical practice

D'Cruz LG, Husain SA, Wells T, Morgan C, Stanczyk PJ, Satgunarajah A, Kashir J, Calver BL, Blayney LM, Lai FA.
PMID: 29755960
J Aging Res Clin Pract. 2018 Mar 26;7:47-54. doi: 10.14283/jarcp.2018.10.

OBJECTIVES: Does excessive sun-exposure, non-use of sunscreen and/or high doses of vitamin-D3 supplements provoke exacerbation of asthma?DESIGN: Clinical examinations, retrospective records-access and questionnaire surveys were distributed to a convenience sample of allergic-asthma patient (n=183).SETTING: Patients (19-89 years) attending the...

Cite
D'Cruz LG, Husain SA, Wells T, et al. Long Sun-Exposures Influencing High Sub-Cutaneous Synthesis of Vitamin-D3 may be Associated with Exacerbation of Symptoms in Allergic-Asthma. J Aging Res Clin Pract. 2018;7:47-54doi: 10.14283/jarcp.2018.10.
D'Cruz, L. G., Husain, S. A., Wells, T., Morgan, C., Stanczyk, P. J., Satgunarajah, A., Kashir, J., Calver, B. L., Blayney, L. M., & Lai, F. A. (2018). Long Sun-Exposures Influencing High Sub-Cutaneous Synthesis of Vitamin-D3 may be Associated with Exacerbation of Symptoms in Allergic-Asthma. The journal of aging research & clinical practice, 747-54. https://doi.org/10.14283/jarcp.2018.10
D'Cruz, L G, et al. "Long Sun-Exposures Influencing High Sub-Cutaneous Synthesis of Vitamin-D3 may be Associated with Exacerbation of Symptoms in Allergic-Asthma." The journal of aging research & clinical practice vol. 7 (2018): 47-54. doi: https://doi.org/10.14283/jarcp.2018.10
D'Cruz LG, Husain SA, Wells T, Morgan C, Stanczyk PJ, Satgunarajah A, Kashir J, Calver BL, Blayney LM, Lai FA. Long Sun-Exposures Influencing High Sub-Cutaneous Synthesis of Vitamin-D3 may be Associated with Exacerbation of Symptoms in Allergic-Asthma. J Aging Res Clin Pract. 2018 Mar 26;7:47-54. doi: 10.14283/jarcp.2018.10. PMID: 29755960; PMCID: PMC5947765.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 40 entries